Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection

被引：0
|
作者：
Hyungjin Kim
Kum Ju Chae
Soon Ho Yoon
Miso Kim
Bhumsuk Keam
Tae Min Kim
Dong-Wan Kim
Jin Mo Goo
Chang Min Park
机构：
[1] Seoul National University Medical Research Centre,Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine
[2] Chonbuk National University Medical School and Hospital,Department of Radiology, Institute of Medical Science, and Research Institute of Clinical Medicine
[3] Seoul National University Cancer Research Institute,Department of Internal Medicine
[4] Seoul National University Hospital,undefined
来源：
European Radiology | 2018年 / 28卷
关键词：
Non-small-cell lung carcinoma; Epidermal growth factor receptor; Protein kinase inhibitor; Drug resistance; Image-guided biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 868
页数：7
相关论文
共 50 条
  • [41] First Experience with Osimertinib in Patients with Newly Developed T790M Mutation Previously Treated with EGFR - TKIs in Croatia
    Jakopovic, M.
    Bitar, L.
    Seiwerth, F.
    Plestina, S.
    Kukulj, S.
    Seiwerth, S.
    Misic, M.
    Redzepi, G.
    Samarzija, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2224 - S2224
  • [42] EGFR T790M Detection Differences by Original Mutation Types and Detection Samples
    Wang, C.
    Wu, W.
    Xiong, M.
    Wu, C.
    Ni, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S441 - S441
  • [43] Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M
    Jancarikova, D.
    Pesek, M.
    Benesova, L.
    Topolcan, O.
    Holubec, L., Jr.
    Minarik, M.
    ANTICANCER RESEARCH, 2007, 27 (4A) : 1879 - 1882
  • [44] Acquired resistance to TKIs in NSCLC; detection of low level T790M using an LNA clamp sequencing method
    Scott, P.
    Tracey, J.
    Kerr, K. M.
    Nicolson, M.
    Clark, C.
    LUNG CANCER, 2014, 83 : S3 - S3
  • [45] The impact of the EGFR-T790M mutation detection by re-biopsy in EGFR mutant NSCLC patients in the retrospective analysis
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okura, Naoko
    Uchino, Junji
    Takayama, Koichi
    CANCER RESEARCH, 2019, 79 (13)
  • [46] Feasibility of liquid biopsy using extracellular vesicle-derived DNA isolated from bronchoalveolar lavage fluid and plasma in addition to tissue rebiopsy to detect T790M mutation in NSCLC patients with acquired resistance to EGFR-TKIs
    Lee, Jong Sik
    Kim, Hee Joung
    Kim, In Ae
    Hur, Jae Young
    Lee, Kye Young
    CANCER RESEARCH, 2018, 78 (13)
  • [47] The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
    Tseng, Jeng-Sen
    Su, Kang-Yi
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Chen, Hsuan-Yu
    Tsai, Chi-Ren
    Yu, Sung-Liang
    Chang, Gee-Chen
    ONCOTARGET, 2016, 7 (30) : 48059 - 48069
  • [48] Acquired T790M resistance do afatinib in EGFR mutated lung adenocarcinoma
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (04): : 317 - 318
  • [49] Liquid Biopsy in EGFR-Mutated Advanced NSCLC from T790M to MET Amplification: Clinical Implications and Possibilities in the Resistance Setting
    Della Gravara, Luigi
    Battiloro, Ciro
    Avellino, Aniello
    Caputo, Francesca
    D'Aniello, Carmine
    Rocco, Danilo
    JOURNAL OF MOLECULAR PATHOLOGY, 2023, 4 (02): : 81 - 88
  • [50] Acquired concurrent EGFR T790M and driver gene resistance from EGFR-TKIs hampered osimertinib efficacy in advanced lung adenocarcinoma
    Wu, F.
    Zeng, Y.
    Feng, Y.
    Fu, G.
    Jiang, J.
    Liu, X.
    Pan, Y.
    Hu, C.
    Liu, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S58 - S59
12345